A Three-part Study to Determine the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Volunteers and Healthy Male Japanese Subjects
Clinical trial NCT01818011 · TERMINATED
Trial details
- NCT number
- NCT01818011
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-07
- Primary completion
- 2013-10-18
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.